Saltar al contenido
MilliporeSigma

Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports (2013-03-29)
Alicia Anderson, Henk Bijlmer, Pierre-Edouard Fournier, Stephen Graves, Joshua Hartzell, Gilbert J Kersh, Gijs Limonard, Thomas J Marrie, Robert F Massung, Jennifer H McQuiston, William L Nicholson, Christopher D Paddock, Daniel J Sexton
RESUMEN

Q fever, a zoonotic disease caused by the bacterium Coxiella burnetii, can cause acute or chronic illness in humans. Transmission occurs primarily through inhalation of aerosols from contaminated soil or animal waste. No licensed vaccine is available in the United States. Because many human infections result in nonspecific or benign constitutional symptoms, establishing a diagnosis of Q fever often is challenging for clinicians. This report provides the first national recommendations issued by CDC for Q fever recognition, clinical and laboratory diagnosis, treatment, management, and reporting for health-care personnel and public health professionals. The guidelines address treatment of acute and chronic phases of Q fever illness in children, adults, and pregnant women, as well as management of occupational exposures. These recommendations will be reviewed approximately every 5 years and updated to include new published evidence.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Doxiciclina hyclate
Sigma-Aldrich
Doxycycline Hydrochloride, Ready Made Solution
Sigma-Aldrich
Doxycycline monohydrate
Supelco
Doxiciclina hyclate, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Doxiciclina hyclate, VETRANAL®, analytical standard